Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
LT010
- Development stage
- Phase 1
- Lead developer
- Chengdu Lingtai Krypton Biotechnology
- Modality
- RNA Therapeutics → Nucleic Acid Therapeutics
- Administration
- Topical
01
Overview
LT010 is an investigational anti-hair loss product currently undergoing safety and efficacy testing. It is being developed by IncTAC Biotechnology Co., Ltd. and West China Hospital, Sichuan University, for the treatment of hair loss.
- Other names
- LT 010LT010LT-010
Beyond the preview
Go deeper on LT010.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on LT010.